Pediatric Germ Cell Tumors; A 10-year Experience

authors:

avatar Ahmad Khaleghnejad-Tabari 1 , * , avatar Alireza Mirshemirani 2 , avatar Mohsen Rouzrokh 3 , avatar Leily Mohajerzadeh 4 , avatar Nasibeh Khaleghnejad-Tabari 5 , avatar shaghayegh Hasas-Yeganeh 6

Iranian Journal of Pediatrics: Vol.24, issue 4; 441-444
published online: July 25, 2014
article type: Rapid Communication
received: June 23, 2013
accepted: December 12, 2013

How To Cite Khaleghnejad-Tabari A , Mirshemirani A , Rouzrokh M , Mohajerzadeh L , Khaleghnejad-Tabari N , et al. Pediatric Germ Cell Tumors; A 10-year Experience. Iran J Pediatr. 2014;24(4): 441-444. 

Abstract

Objective: The aim of this study was to evaluate the outcome of germ cell tumors in patients admitted to our center during a ten year period.Methods: In a retrospective descriptive study, patients with the pathological diagnosis of germ cell tumor (GCT) were included. All records were evaluated and patients followed by personal visit in clinic or phone call. Data regarding age, sex, tumor site, bio-chemical assay, pathology, treatment and outcomes were gathered. For qualitative variables we computed frequency and percentage and for quantitative variables, mean and standard deviation. Survival analysis was performed using Kaplan-Meier. All statistical analyses were performed by SPSS version16.0.Findings: Forty four patients consisted of 32 girls (72.7%) and 12 boys (27.3%). Their median age was 23 months. The most common pathological tumor types were 18 (40.9%) mature teratomas and 14 (31.8%) yolk sac tumors. Extra gonadal tumors were more prevalent (32 cases) and consisted of 21 (47.7%) sacrcoccygeal, 7 (15.9%) retroperitoneal, 2 (4.4%) mediastinal and 2 (4.4%) cervical tumors. In gonadal tumors 9 patients had ovarian and 3 patients testicular involvement. Staging at the time of diagnosis revealed stage one in 23 (52.3%) cases. All patients were treated surgically and the most common procedure was total resection in 41 (93.2%) patients. Fifteen (34.1%) patients received chemotherapy. In follow-up 31 (77.5%) patients were in complete remission, 9 (22.5%) had died, and 4 cases did not appear to follow-up visits. The median survival was 16 months (IQR 4-49 months). The highest mortality rate was found in patients with yolk sac tumors (8 of 13 cases).Conclusion: The patients with extra-gonadal GCT and a high AFP level have the worst prognosis and lower survival rate. Combination of surgery and chemotherapy can lead to a better prognosis.
 

Fulltext

Click here to download PDF.

References

  • 1.

    References are available on the PDF.